After settlement of the third case to head to the courtroom in Philadelphia’s Risperdal mass tort, the lead trial attorney for the plaintiffs said it is too soon to expect a global resolution of the litigation.

On May 27, the day opening arguments were scheduled in Walker v. Janssen Pharmaceuticals, the case settled for a confidential amount, according to Thomas R. Kline of Kline & Specter, who is trying Risperdal cases with co-counsel Christopher A. Gomez and Stephen A. Sheller of Sheller P.C.